# Chlorhexidine Gluconate Versus Mupirocin Ointment in the Prevention of Peritoneal Dialysis-Related Infection

Study · id `cardio:ct-nct02547103` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02547103](<https://clinicaltrials.gov/study/NCT02547103>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02547103

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 354 participants.

## Technical summary

Registry record NCT02547103. Randomized; quadruple masking; primary purpose prevention. Start 2016-06-01 (actual); primary completion 2021-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 354 participants (planned count; ClinicalTrials.gov record NCT02547103, source copy `cardio:ctgov-nct02547103-2019-07-29`, retrieved 2026-10-26)
- Started: 2016-06-01 (actual) (ClinicalTrials.gov record NCT02547103, source copy `cardio:ctgov-nct02547103-2019-07-29`, retrieved 2026-10-26)
- Primary completion: 2021-06-30 (anticipated) (ClinicalTrials.gov record NCT02547103, source copy `cardio:ctgov-nct02547103-2019-07-29`, retrieved 2026-10-26)
- Completion: 2021-08 (anticipated) (ClinicalTrials.gov record NCT02547103, source copy `cardio:ctgov-nct02547103-2019-07-29`, retrieved 2026-10-26)
- Countries: Thailand (ClinicalTrials.gov record NCT02547103, source copy `cardio:ctgov-nct02547103-2019-07-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02547103-2019-07-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Chlorhexidine Gluconate Versus Mupirocin Ointment in the Prevention of Peritoneal Dialysis-Related Infection
- Acronym: COSMO-PD
- Condition: End Stage Renal Disease
- Condition: Peritoneal Dialysis
- Intervention (Other): Chlorhexidine gluconate-soaked cloths
- Intervention (Other): Normal saline
- Intervention (Other): mupirocin ointment
- Lead sponsor: Chiang Mai University
- Lead sponsor class: OTHER
- Collaborator: Health Systems Research Institute,Thailand
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 3ffe382c6d6c6e9f7adb7ede024489e16e862e267833f8bd8f4bcd0170b01394
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
